Is mazdutide approved anywhere?

Mazdutide received its first regulatory approval in China for chronic weight management in 2025.

Mazdutide Calculator

Also known as: IBI362, LY3305677

GLP-1

Default: 9mg / 2mL / 3mgAdjust inputs to match your vial

About

What is Mazdutide?

Mazdutide is a glucagon/GLP-1 dual agonist licensed from Eli Lilly to Innovent Biologics for development in China. Phase 3 obesity data show 11–14% weight loss at 32 weeks.

Common vial sizes

6 mg	lyophilized powder
9 mg	lyophilized powder

Reference dose ranges

3 mg	≈ 66.7 U-100 units (at 9mg / 2mL)
4.5 mg	≈ 100 U-100 units (at 9mg / 2mL)
6 mg	≈ 133 U-100 units (at 9mg / 2mL)
9 mg	≈ 200 U-100 units (at 9mg / 2mL)

Reconstitution

How it's typically prepared

Reconstitute with BAC water; refrigerate.

FAQ

Frequently asked questions

Is mazdutide approved anywhere?: Mazdutide received its first regulatory approval in China for chronic weight management in 2025.

Sources

References

PubMed search: mazdutide

Other GLP-1 peptides

Notice

PeptideDose is an educational reference. It is not medical advice and does not replace consultation with a licensed healthcare provider. Doses shown in presets are derived from published protocols and product labels — they are not personal recommendations.